Trial Profile
A 4-Day, Randomized, Controlled Study to Evaluate the Phototoxicity Potential of FMX-101, 4% in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris; Impetigo; Rosacea
- Focus Adverse reactions
- Sponsors Foamix
- 26 Aug 2019 Status changed from planning to completed.
- 18 May 2016 New trial record
- 10 May 2016 According to a Foamix media release, data from this study will be used for the filing of a new drug application.